Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger ...

Roberts and his Beta 480 RR Race are fast. They secured the 2024 NHHA title and remain undefeated after two rounds in 2025, ...

Biogen Inc. investors can advance their claim that the company misrepresented clinical trial data for its Alzheimer’s drug, a federal judge ruled.

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...